Skip to main content
Clinical Trials/CTRI/2020/02/023194
CTRI/2020/02/023194
Completed
未知

A Prospective Study to Evaluate the Safety and Efficacy of Levetiracetam in Comparison To Magnesium Sulphate in the Management of Severe Pre â?? Eclampsia and Imminent Eclampsia. - SELCOMSUPE

BLDE Deemed to be University0 sites30 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
BLDE Deemed to be University
Enrollment
30
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
BLDE Deemed to be University

Eligibility Criteria

Inclusion Criteria

  • 1\.All pregnant women with gestational age above 28 weeks presenting with features of severe pre eclampsia and imminent eclampsia during the period will be recruited into the study
  • 2\.Patients giving informed and written consent for investigations

Exclusion Criteria

  • 1\.Patients who were diagnosed with other causes of convulsions in pregnancy like cerebral malaria and epilepsy
  • 2\.Chronic hypertensive pregnant females
  • 3\.Pregnant females with fetal anomalies detected on USG
  • 4\.Patients who withdraw the consent for further participation in the study

Outcomes

Primary Outcomes

Not specified

Similar Trials